Patents Assigned to Woomera Therapeutics, Inc.
  • Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
    Patent number: 7790162
    Abstract: The present invention discloses antibodies, antigen binding fragments, peptides and peptidomimetics immunoreactive with provasopressin and compositions thereof, methods of phenotyping tissue samples, methods of treating cancer, and kits for phenotyping test biopsy samples and bodily fluids for breast cancer, small cell lung cancer, ductal carcinoma in situ, and atypical ductal hyperplasia.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: September 7, 2010
    Assignee: Woomera Therapeutics, Inc.
    Inventors: William G. North, Brendan P. Keegan, Lyn Oligino